The Preclinical Imaging Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Preclinical Imaging Market:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

According to The Business Research Company’s Preclinical Imaging Global Market Report 2024, The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%.  The growth in the historic period can be attributed to government initiatives, growing prevalence of diseases, expanding applications, increasing awareness, emerging markets expansion.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.  The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, rise in r&d activities, collaborations and partnerships, real-time imaging.

The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person's quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Product innovations are a key trend gaining popularity in the preclinical imaging market. Major companies operating in the preclinical imaging market are developing innovative products to sustain their position in the market. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company that manufactures imaging systems, launched Vevo F2 for preclinical imaging. This innovative product is the first preclinical ultra-high- to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 features HD image processing technology and a completely new signal pathway, enabling better image clarity and better frame rates. The system is also customizable to fit the specific precision demands of imaging. Additionally, it includes features such as HD image processing technology, a completely new signal pathway, customizable system architecture, a wide range of anatomical targets, and high-resolution imaging. It is suitable for a variety of research applications.

The preclinical imaging market report table of contents includes:
1. Executive Summary
2. Preclinical Imaging Market Characteristics
3. Preclinical Imaging Market Trends And Strategies
4. Preclinical Imaging Market - Macro Economic Scenario
5. Global Preclinical Imaging Market Size and Growth
.......................
31. Preclinical Imaging Market Other Major And Innovative Companies
32. Global Preclinical Imaging Market Competitive Benchmarking
33. Global Preclinical Imaging Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Preclinical Imaging Market
35. Preclinical Imaging Market Future Outlook and Potential Analysis

Read Related Topics:
https://goodprnews.com/warts-therapeutics-global-market-size/
https://goodprnews.com/white-box-server-global-market-size/
https://goodprnews.com/wi-fi-chipset-global-market-size/
https://topprnews.com/warts-therapeutics-global-market-share/
https://topprnews.com/white-box-server-global-market-share/
https://topprnews.com/wi-fi-chipset-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model